SEC Form 4 · accession 0001571049-15-006662

PHIBRO ANIMAL HEALTH CORP · PAHC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

10% Owner

Period of report

Aug 10, 2015

Accepted (ET)

Aug 12, 2015 · 9:01 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001069899

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Class A Common Stock^F1	Aug 10, 2015	C	20,807	—	A	84,000	D
Class A Common Stock^F2,F3	Aug 10, 2015	S	7,300	$39.538	D	76,700	D
Class A Common Stock^F2,F4	Aug 11, 2015	S	8,457	$39.281	D	68,243	D
Class A Common Stock^F2,F5	Aug 12, 2015	S	6,900	$39.07	D	61,343	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Class B Common Stock^F1	—	Aug 10, 2015	C	20,807	D	—	—	Class A Common Stock	20,807	21,208,468	D

F1The Class B Common Stock was convertible into Class A Common Stock at any time on a one-for-one basis, and had no expiration date.
F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2015.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.56 to $40.09, inclusive.
F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.52 to $40.05, inclusive.
F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.35 to $40.185, inclusive.